BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 36891319)

  • 1. T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications.
    Chi X; Luo S; Ye P; Hwang WL; Cha JH; Yan X; Yang WH
    Front Immunol; 2023; 14():1104771. PubMed ID: 36891319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion.
    Li F; Wang Y; Chen D; Du Y
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schrödinger's T Cells: Molecular Insights Into Stemness and Exhaustion.
    Gonzalez NM; Zou D; Gu A; Chen W
    Front Immunol; 2021; 12():725618. PubMed ID: 34512656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into T-cell exhaustion in liver cancer: from mechanism to therapy.
    Hao L; Li S; Hu X
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12543-12560. PubMed ID: 37423958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8
    Wang Q; Qin Y; Li B
    Cancer Lett; 2023 Apr; 559():216043. PubMed ID: 36584935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor microenvironment shapes the molecular characteristics of exhausted CD8
    Cheng H; Ma K; Zhang L; Li G
    Cancer Lett; 2021 May; 506():55-66. PubMed ID: 33662493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion.
    Gumber D; Wang LD
    EBioMedicine; 2022 Mar; 77():103941. PubMed ID: 35301179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8
    Huang Y; Jia A; Wang Y; Liu G
    Immunology; 2023 Jan; 168(1):30-48. PubMed ID: 36190809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
    Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
    Front Immunol; 2020; 11():622509. PubMed ID: 33633741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. γδ T cell exhaustion: Opportunities for intervention.
    Chen D; Guo Y; Jiang J; Wu P; Zhang T; Wei Q; Huang J; Wu D
    J Leukoc Biol; 2022 Dec; 112(6):1669-1676. PubMed ID: 36000310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Correlation Between Differentiation Phenotypes of Infused T Cells and Anti-Cancer Immunotherapy.
    Ren H; Cao K; Wang M
    Front Immunol; 2021; 12():745109. PubMed ID: 34603332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment.
    Zhao Y; Shao Q; Peng G
    Cell Mol Immunol; 2020 Jan; 17(1):27-35. PubMed ID: 31853000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of T cell exhaustion for cancer immunotherapy.
    Chow A; Perica K; Klebanoff CA; Wolchok JD
    Nat Rev Clin Oncol; 2022 Dec; 19(12):775-790. PubMed ID: 36216928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engaging stemness improves cancer immunotherapy.
    Dianat-Moghadam H; Sharifi M; Salehi R; Keshavarz M; Shahgolzari M; Amoozgar Z
    Cancer Lett; 2023 Feb; 554():216007. PubMed ID: 36396102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies.
    Tang L; Zhang Y; Hu Y; Mei H
    Biomed Res Int; 2021; 2021():6616391. PubMed ID: 33728333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell exhaustion in malignant gliomas.
    Watowich MB; Gilbert MR; Larion M
    Trends Cancer; 2023 Apr; 9(4):270-292. PubMed ID: 36681605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy.
    He QF; Xu Y; Li J; Huang ZM; Li XH; Wang X
    Brief Funct Genomics; 2019 Mar; 18(2):99-106. PubMed ID: 29554204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment.
    Crespo J; Sun H; Welling TH; Tian Z; Zou W
    Curr Opin Immunol; 2013 Apr; 25(2):214-21. PubMed ID: 23298609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities.
    Brunell AE; Lahesmaa R; Autio A; Thotakura AK
    Front Immunol; 2023; 14():1151632. PubMed ID: 37122741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy.
    Trefny MP; Kirchhammer N; Auf der Maur P; Natoli M; Schmid D; Germann M; Fernandez Rodriguez L; Herzig P; Lötscher J; Akrami M; Stinchcombe JC; Stanczak MA; Zingg A; Buchi M; Roux J; Marone R; Don L; Lardinois D; Wiese M; Jeker LT; Bentires-Alj M; Rossy J; Thommen DS; Griffiths GM; Läubli H; Hess C; Zippelius A
    Nat Commun; 2023 Feb; 14(1):86. PubMed ID: 36732507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.